首页> 外文期刊>Nature medicine >CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
【24h】

CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.

机译:对于人类淋巴组织中的T细胞靶标,CCR5-和CXCR4-tropic HIV-1具有相同的细胞病变性。

获取原文
获取原文并翻译 | 示例
           

摘要

A rapid decline in T-cell counts and the progression to AIDS is often associated with a switch from CCR5-tropic (R5) HIV-1 to CXCR4-tropic (X4) HIV-1 or R5/X4 HIV-1 variants. Experimental infection with R5 HIV-1 causes less T-cell depletion than infection with X4 or R5/X4 variants in T-cell cultures, in ex vivo infected human lymphoid tissue and in SCID/hu mice, despite similar replication levels. Experimental genetic changes in those sequences in gp120 that transform R5 HIV-1 variants into otherwise isogenic X4 viruses make them highly cytopathic. Thus, it is now believed that R5 variants are less cytopathic for T cells than are X4 variants. However, it is not known why CCR5-mediated HIV-1 infection does not lead to a massive CD4+ T-cell depletion, as occurs in CXCR4-mediated HIV-1 infection. Here we demonstrate that R5 HIV-1 isolates are indeed highly cytopathic, but only for CCR5+/CD4+ T cells. Because these cells constitute only a small fraction of CD4+ T cells, their depletion does not substantially change the total CD4+ T-cell count. These results may explain why the clinical stage of HIV disease correlates with viral tropism.
机译:T细胞计数的快速下降和向AIDS的发展通常与从CCR5-tropic(R5)HIV-1到CXCR4-tropic(X4)HIV-1或R5 / X4 HIV-1变体的转换有关。尽管复制水平相似,但在T细胞培养物中,离体感染的人淋巴组织和SCID / hu小鼠中,用R5 HIV-1进行的实验性感染引起的T细胞耗竭要少于X4或R5 / X4变体的感染。 gp120中将R5 HIV-1变异体转化为同基因X4病毒的gp120序列中的实验性遗传变化,使其具有高度的细胞病变性。因此,现在认为R5变体对T细胞的细胞病变性小于X4变体。但是,还不知道为什么CCR5介导的HIV-1感染不会像CXCR4介导的HIV-1感染那样导致大量CD4 + T细胞耗竭。在这里,我们证明R5 HIV-1分离物确实具有高度的细胞病变性,但仅适用于CCR5 + / CD4 + T细胞。由于这些细胞仅占CD4 + T细胞的一小部分,因此它们的耗竭基本上不会改变CD4 + T细胞的总数。这些结果可以解释为什么HIV疾病的临床阶段与病毒嗜性相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号